Monte Rosa Therapeutics, Inc. (GLUE) reported Q2 Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq set for sharp drop as Amazon, Intel amplify AI spending worries
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
| (NASDAQ: GLUE) | Delayed: 10.80 -0.07 (0.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.87 | 52 Week High | $ | |||
| Open | $10.85 | 52 Week Low | $ | |||
| Day High | $11.13 | P/E | N/A | |||
| Day Low | $10.67 | EPS | $ | |||
| Volume | 60,451 | |||||
